Skip to Main Content
1-877-YALEMDS
SpecialistsFact SheetsDepartmentsClinical TrialsNewsPatient ToolsFor Medical Professionals
1-877-YALEMDS
  • Search
  • Clinical Trials
  • Joseph Lim

Clinical Trials

    • Liver(2)
  • Liver

    A Phase 3 Study Evaluating Long-term Efficacy and Safety of Lanifibranor in Adult Patients With (NASH) and Fibrosis 2 (F2)/Fibrosis 3 (F3) Stage of Liver Fibrosis (NATiV3)

    • Ages18 years and older
    • GenderBoth
  • Liver

    Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA) (MIRNA)

    • Ages18 years - 75 years
    • GenderBoth
  • About Us
  • Contact Us
  • Donate
  • Referring Doctors
  • Clinical Keywords

333 Cedar St.

New Haven, CT 06510

  • Yale School of Medicine
  • Yale University
  • Terms & Privacy Policies
  • Accessibility at YSM
  • Patient Rights
  • HIPAA at Yale
  • Non-discrimination Statement
Copyright 2025 Yale Medicine